Introducing NEW Evrysdi tablets*

For illustrative purposes only.

*Evrysdi 5-mg tablets are approved for people aged 2 years and older who weigh at least 44 lb (20 kg). The tablets cannot be taken with feeding tubes.

Learn more about Evrysdi tablets

About Evrysdi tablets

The only oral, non-invasive spinal muscular atrophy (SMA) treatment, now in a tablet

The proven results and safety of the liquid form now come with the flexibility of a tablet.

Why Evrysdi tablets may be the right choice for you

Stored at room temperature

Whether at work or on vacation, you can travel with Evrysdi tablets without the need for a cooler bag

Made to fit your lifestyle

You can choose to swallow the tablet whole with water or as a mixture with non-chlorinated drinking water (eg, filtered water, bottled water)—whichever works best for you

No need for measuring

Each once-daily Evrysdi tablet already contains your dose

68°F to 77°F (20°C to 25°C).

Your experience with SMA might be different from others—that’s why having options in how you choose to take Evrysdi is important. Ask your doctor if Evrysdi tablets are right for you

Frequently asked questions

Click on the questions below to learn more about Evrysdi tablets

Lean about icon

Could Evrysdi tablets be right for you?

Download a printable selection of this information to discuss with your doctor.

Important Safety Information and Indication

What is Evrysdi?

Evrysdi is a prescription medicine used to treat spinal muscular atrophy (SMA) in children and adults.

  • Before taking Evrysdi, tell your healthcare provider about all of your medical conditions, including if you:
    • are pregnant or plan to become pregnant, as Evrysdi may harm your unborn baby. Ask your healthcare provider for advice before taking this medicine
    • are a woman who can become pregnant:
      • Before you start your treatment with Evrysdi, your healthcare provider may test you for pregnancy
      • Talk to your healthcare provider about birth control methods that may be right for you. Use birth control while on treatment and for at least 1 month after stopping Evrysdi
      • Pregnancy Registry. There is a pregnancy registry for women who take Evrysdi during pregnancy. The purpose of this registry is to collect information about the health of the pregnant woman and her baby. If you are pregnant or become pregnant while receiving Evrysdi, tell your healthcare provider right away. Talk to your healthcare provider about registering with the Evrysdi Pregnancy Registry. Your healthcare provider can enroll you in this registry or you can enroll by calling 1-833-760-1098 or visiting www.evrysdipregnancyregistry.com.
    • are an adult male. Evrysdi may affect a man’s ability to have children (fertility). Ask a healthcare provider for advice before taking this medicine
    • are breastfeeding or plan to breastfeed. It is not known if Evrysdi passes into breast milk and may harm your baby
  • Tell your healthcare provider about all the medicines you take
  • If you were prescribed Evrysdi for Oral Solution, you should receive Evrysdi from the pharmacy as a liquid. If the medicine in the bottle is a powder, do not use it. Contact your pharmacist for a replacement
  • Avoid getting Evrysdi on your skin or in your eyes. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water
  • The most common side effects of Evrysdi include:
    • For later-onset SMA:
      • fever
      • diarrhea
      • rash
    • For infantile-onset SMA:            
      • fever
      • diarrhea
      • rash
      • runny nose, sneezing, and sore throat (upper respiratory infection)
      • lung infection (lower respiratory infection)
      • constipation
      • vomiting
      • cough

These are not all of the possible side effects of Evrysdi. For more information on the risk and benefits profile of Evrysdi, ask your healthcare provider or pharmacist.

You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555.

Please see full Prescribing Information for additional Important Safety Information.